Compounds > isoxazoles
Page last updated: 2024-08-21

isoxazoles and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole

isoxazoles has been researched along with 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Perrone, MG; Scilimati, A; Simone, L; Vitale, P1
Armen, RS; Cingolani, G; Di Mauro, G; Ferorelli, S; Fortuna, CG; Panella, A; Perrone, MG; Scilimati, A; Smith, WL; Vitale, P1

Reviews

1 review(s) available for isoxazoles and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole

ArticleYear
Selective COX-1 inhibition: A therapeutic target to be reconsidered.
    Current medicinal chemistry, 2010, Volume: 17, Issue:32

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Endothelial Cells; Female; Humans; Isoxazoles; Neoplasms; Nervous System Diseases; Obstetric Labor, Premature; Pain; Pregnancy

2010

Other Studies

1 other study(ies) available for isoxazoles and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole

ArticleYear
Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole (P6).
    European journal of medicinal chemistry, 2017, Sep-29, Volume: 138

    Topics: Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Humans; Isoxazoles; Molecular Structure; Structure-Activity Relationship

2017